26.81
1.02 (3.93%)
| Previous Close | 25.80 |
| Open | 26.23 |
| Volume | 564,153 |
| Avg. Volume (3M) | 553,757 |
| Market Cap | 1,595,310,208 |
| Price / Sales | 3.43 |
| Price / Book | 5.41 |
| 52 Weeks Range | |
| Earnings Date | 2 Sep 2025 - 8 Sep 2025 |
| Profit Margin | -9.83% |
| Operating Margin (TTM) | -46.68% |
| Diluted EPS (TTM) | -0.740 |
| Quarterly Revenue Growth (YOY) | 45.70% |
| Total Debt/Equity (MRQ) | 2.60% |
| Current Ratio (MRQ) | 1.95 |
| Operating Cash Flow (TTM) | 47.95 M |
| Levered Free Cash Flow (TTM) | 35.26 M |
| Return on Assets (TTM) | -5.98% |
| Return on Equity (TTM) | -15.97% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Phreesia, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | -2.5 |
| Price Volatility | -1.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | -0.5 |
| Average | -0.20 |
|
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 4.31% |
| % Held by Institutions | 97.41% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 35.00 (Truist Securities, 30.55%) | Buy |
| Median | 34.00 (26.82%) | |
| Low | 28.00 (Keybanc, 4.44%) | Buy |
| Average | 32.75 (22.16%) | |
| Total | 4 Buy | |
| Avg. Price @ Call | 24.14 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Canaccord Genuity | 29 May 2025 | 34.00 (26.82%) | Buy | 24.43 |
| Truist Securities | 29 May 2025 | 35.00 (30.55%) | Buy | 24.43 |
| Keybanc | 16 Apr 2025 | 28.00 (4.44%) | Buy | 23.89 |
| DA Davidson | 14 Apr 2025 | 34.00 (26.82%) | Buy | 23.82 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Jun 2025 | Announcement | Becker’s Names Phreesia’s Kristin Roberts as one of 2025’s 100 Women in Health IT to Know |
| 28 May 2025 | Announcement | Phreesia Announces First Quarter Fiscal 2026 Results |
| 06 May 2025 | Announcement | Phreesia Updates May 28, 2025, Earnings Release Information for Fiscal First Quarter 2026 Results |
| 29 Apr 2025 | Announcement | Phreesia Sets Release Date for Fiscal First Quarter 2026 Results |
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 May 2013 | 07 Feb 2013 | 17 Jun 2013 | 0.5625 Cash |
| 27 Feb 2013 | 06 Feb 2013 | 15 Mar 2013 | 0.5625 Cash |
| 28 Nov 2012 | - | 15 Dec 2012 | 0.5625 Cash |
| 29 Aug 2012 | - | 15 Sep 2012 | 0.5625 Cash |
| 30 May 2012 | - | 15 Jun 2012 | 0.5625 Cash |
| 28 Feb 2012 | - | 15 Mar 2012 | 0.5625 Cash |
| 30 Aug 2011 | - | 15 Sep 2011 | 0.5625 Cash |
| 27 May 2011 | - | 15 Jun 2011 | 0.5625 Cash |
| 25 Feb 2011 | - | 15 Mar 2011 | 0.5625 Cash |
| 29 Nov 2010 | - | 15 Dec 2010 | 0.5625 Cash |
| 30 Aug 2010 | - | 15 Sep 2010 | 0.5625 Cash |
| 27 May 2010 | - | 15 Jun 2010 | 0.5625 Cash |
| 25 Feb 2010 | - | 15 Mar 2010 | 0.5625 Cash |
| 27 Nov 2009 | - | 15 Dec 2009 | 0.5625 Cash |
| 28 Aug 2009 | - | 15 Sep 2009 | 0.5625 Cash |
| 28 May 2009 | - | 15 Jun 2009 | 0.5625 Cash |
| 25 Feb 2009 | - | 16 Mar 2009 | 0.5625 Cash |
| 26 Nov 2008 | - | 15 Dec 2008 | 0.5625 Cash |
| 27 Aug 2008 | - | 15 Sep 2008 | 0.46875 Cash |
| Show more | |||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |